AMRX Amneal Pharmaceuticals PE ratio, current and historical analysis
The current price-to-earnings ratio of AMRX can't be determined, as the TTM EPS of -$0.38 is negative. Amneal Pharmaceuticals's last PE ratio on record was 70.33 in September 2023.
AMRX PE ratio history
The mean historical PE ratio of Amneal Pharmaceuticals over the last five years is 69.94. In the past five years, AMRX's PE ratio was at its highest in the Mar 2022 quarter at 208.5, with a price of $4.17 and an EPS of $0.02. The Dec 2020 quarter recorded the bottom point at 7.37, with a price of $4.57 and an EPS of $0.62.
Amneal Pharmaceuticals PE ratio by year
Maximum annual increase: 828.49% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $7.92 | -$0.38 |
| 2023 | N/A | N/A | $6.07 | -$0.48 |
| 2022 | N/A | N/A | $1.99 | -$0.86 |
| 2021 | 68.43 | 828.49% | $4.79 | $0.07 |
| 2020 | 7.37 | N/A | $4.57 | $0.62 |
| 2019 | N/A | N/A | $4.82 | -$2.74 |
| 2018 | N/A | N/A | $13.53 | -$0.16 |
| 2017 | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A |
| 2015 | N/A | N/A | N/A | N/A |
| 2014 | N/A | N/A | N/A | N/A |
Amneal Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $7.92 | -$0.38 |
| Sep 2024 | N/A | N/A | $8.32 | -$0.86 |
| Jun 2024 | N/A | N/A | $6.35 | -$0.8 |
| Mar 2024 | N/A | N/A | $6.06 | -$0.74 |
| Dec 2023 | N/A | N/A | $6.07 | -$0.48 |
| Sep 2023 | 70.33 | N/A | $4.22 | $0.06 |
| Jun 2023 | N/A | N/A | $3.1 | -$0.02 |
| Mar 2023 | N/A | N/A | $1.39 | -$0.9 |
| Dec 2022 | N/A | N/A | $1.99 | -$0.86 |
| Sep 2022 | N/A | N/A | $2.02 | -$0.87 |
| Jun 2022 | N/A | N/A | $3.18 | -$0.88 |
| Mar 2022 | 208.5 | 204.69% | $4.17 | $0.02 |
| Dec 2021 | 68.43 | 28.15% | $4.79 | $0.07 |
| Sep 2021 | 53.4 | -26.99% | $5.34 | $0.1 |
| Jun 2021 | 73.14 | N/A | $5.12 | $0.07 |
AMRX average PE ratio chart
AMRX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPTN OptiNose Inc | N/A | $92.26M |
| AMRX Amneal Pharmaceuticals Inc | N/A | $2.53B |
Frequently asked questions
What is Amneal Pharmaceuticals's PE ratio?
The current price to earnings ratio of AMRX can't be calculated, as its EPS of -$0.38 is negative.
What is the 5-year average PE ratio for Amneal Pharmaceuticals (AMRX)?
As an average over the last 5 years, AMRX stock has a PE ratio of 69.94.
What is the highest PE ratio for AMRX?
The highest quarterly PE ratio in the last five years has been 208.5 and it was in the Mar 2022 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.